These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 32965348)
1. Immune status could be associated with severity in COVID-19 patients. Liu C; Yang J; Wang W; Mi Y; Tang Y; Zheng P Rev Assoc Med Bras (1992); 2020; 66Suppl 2(Suppl 2):13-16. PubMed ID: 32965348 [No Abstract] [Full Text] [Related]
2. Cellular immune responses to covid-19. Sewell HF; Agius RM; Stewart M; Kendrick D BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031 [No Abstract] [Full Text] [Related]
4. New view on older adults with COVID-19: comments on "SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes". Xu G; Ye M; Zhao J; Liu F; Ma W Geroscience; 2020 Oct; 42(5):1225-1227. PubMed ID: 32710258 [No Abstract] [Full Text] [Related]
5. Will SARS-CoV-2 become endemic? Shaman J; Galanti M Science; 2020 Oct; 370(6516):527-529. PubMed ID: 33055131 [No Abstract] [Full Text] [Related]
6. The paramount importance of serological surveys of SARS-CoV-2 infection and immunity. Goudsmit J Eur J Epidemiol; 2020 Apr; 35(4):331-333. PubMed ID: 32318914 [No Abstract] [Full Text] [Related]
13. A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2. Hanley BP; Keen S; Church G Rejuvenation Res; 2020 Aug; 23(4):281-283. PubMed ID: 32539623 [No Abstract] [Full Text] [Related]
14. Wrong but Useful - What Covid-19 Epidemiologic Models Can and Cannot Tell Us. Holmdahl I; Buckee C N Engl J Med; 2020 Jul; 383(4):303-305. PubMed ID: 32412711 [No Abstract] [Full Text] [Related]
15. The COVID-19 pandemic and the use of MS disease-modifying therapies. Giovannoni G; Hawkes C; Lechner-Scott J; Levy M; Waubant E; Gold J Mult Scler Relat Disord; 2020 Apr; 39():102073. PubMed ID: 32334820 [No Abstract] [Full Text] [Related]
16. Good news or bad news? The coronavirus pandemic has sickened and killed only a relatively few people but has affected us all. Calisher CH Croat Med J; 2020 Jul; 61(3):296-299. PubMed ID: 32643349 [No Abstract] [Full Text] [Related]
18. Immunosuppression drug advice and COVID-19: are we doing more harm than good? Warraich R; Amani L; Mediwake R; Tahir H Br J Hosp Med (Lond); 2020 Jun; 81(6):1-3. PubMed ID: 32589546 [TBL] [Abstract][Full Text] [Related]
19. Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries. Kwok KO; Lai F; Wei WI; Wong SYS; Tang JWT J Infect; 2020 Jun; 80(6):e32-e33. PubMed ID: 32209383 [No Abstract] [Full Text] [Related]
20. Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic? Laxminarayan R; John TJ Indian Pediatr; 2020 Jun; 57(6):505-507. PubMed ID: 32376793 [No Abstract] [Full Text] [Related] [Next] [New Search]